These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36264285)

  • 41. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
    Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
    Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic alterations in gastric amphicrine carcinomas and comparison with gastric mixed neuroendocrine-non-neuroendocrine neoplasms.
    Sun L; Wang C; Zhang J; Shao B; Zhao S; Guo Y; Li X; Sun Y
    Mod Pathol; 2022 Jun; 35(6):808-815. PubMed ID: 34839352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
    Chen K; Yang D; Li X; Sun B; Song F; Cao W; Brat DJ; Gao Z; Li H; Liang H; Zhao Y; Zheng H; Li M; Buckner J; Patterson SD; Ye X; Reinhard C; Bhathena A; Joshi D; Mischel PS; Croce CM; Wang YM; Raghavakaimal S; Li H; Lu X; Pan Y; Chang H; Ba S; Luo L; Cavenee WK; Zhang W; Hao X
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1107-12. PubMed ID: 25583476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genomic characterization of small cell carcinomas of the uterine cervix.
    Schultheis AM; de Bruijn I; Selenica P; Macedo GS; da Silva EM; Piscuoglio S; Jungbluth AA; Park KJ; Klimstra DS; Wardelmann E; Hartmann W; Gerharz CD; von Petersdorff M; Buettner R; Reis-Filho JS; Weigelt B
    Mol Oncol; 2022 Feb; 16(4):833-845. PubMed ID: 33830625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review.
    Girardi DM; Silva ACB; Rêgo JFM; Coudry RA; Riechelmann RP
    Cancer Treat Rev; 2017 May; 56():28-35. PubMed ID: 28456055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.
    Yu S; Hornick JL; Gonzalez RS
    Virchows Arch; 2021 Sep; 479(3):481-491. PubMed ID: 33733343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic and Molecular Characterization of Inflammatory Bowel Disease-Associated Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
    Liao X; Schmidt AL; Zhang D; Li P; Wang X; Ko HM; Choi WT; Alpert L; Hao Y; Kovar-Peltz S; Polydorides AD; Wanjari P; Mastro J; Wang P
    Mod Pathol; 2024 Oct; 37(10):100566. PubMed ID: 39025404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutational analysis of pulmonary large cell neuroendocrine carcinoma: APC gene mutations identify a good prognostic factor.
    Li M; Zhang Y; Zhou P; Miao Y; Li S; Jiang L
    Lung Cancer; 2024 Jun; 192():107825. PubMed ID: 38795461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach.
    Ishida M; Sekine S; Taniguchi H; Fukagawa T; Katai H; Kushima R
    Histopathology; 2014 Jun; 64(7):1027-31. PubMed ID: 24329753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
    Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
    Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
    Linder A; Westbom-Fremer S; Mateoiu C; Olsson Widjaja A; Österlund T; Veerla S; Ståhlberg A; Ulfenborg B; Hedenfalk I; Sundfeldt K
    Hum Reprod; 2024 May; 39(5):1141-1154. PubMed ID: 38459814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
    Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
    Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for
    Li J; Wang J; Su D; Nie X; Liu Y; Teng L; Pang J; Wu H; Liang Z
    Gastroenterol Res Pract; 2021; 2021():2510195. PubMed ID: 34956360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.
    Sun TY; Zhao L; Van Hummelen P; Martin B; Hornbacker K; Lee H; Xia LC; Padda SK; Ji HP; Kunz P
    Endocr Relat Cancer; 2022 Dec; 29(12):665-679. PubMed ID: 36165930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components.
    Scardoni M; Vittoria E; Volante M; Rusev B; Bersani S; Mafficini A; Gottardi M; Giandomenico V; Malleo G; Butturini G; Cingarlini S; Fassan M; Scarpa A
    Neuroendocrinology; 2014; 100(4):310-6. PubMed ID: 25342539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity.
    Woischke C; Jung P; Jung A; Kumbrink J; Eisenlohr S; Auernhammer CJ; Vieth M; Kirchner T; Neumann J
    J Pathol Clin Res; 2021 Jan; 7(1):75-85. PubMed ID: 33197299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Grading of Neuroendocrine Carcinomas: Correlation of
    Liverani C; Bongiovanni A; Mercatali L; Foca F; Pieri F; De Vita A; Spadazzi C; Miserocchi G; Recine F; Riva N; Nicolini S; Severi S; Martinelli G; Ibrahim T
    Dis Markers; 2018; 2018():6878409. PubMed ID: 30627226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RB1 Genetic Alterations in Estrogen Receptor-Positive Breast Carcinomas: Correlation With Neuroendocrine Differentiation.
    Schwartz CJ; Marra A; Selenica P; Gazzo A; Tan K; Ross D; Razavi P; Chandarlapaty S; Weigelt B; Reis-Filho JS; Brogi E; Pareja F; Wen HY
    Mod Pathol; 2024 Aug; 37(8):100541. PubMed ID: 38897452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.
    Iijima M; Yokobori T; Mogi A; Shimizu K; Yajima T; Kosaka T; Ohtaki Y; Obayashi K; Nakazawa S; Gombodorj N; Tsukagoshi M; Shirabe K; Kuwano H
    Ann Surg Oncol; 2019 Jun; 26(6):1744-1750. PubMed ID: 30924018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
    Bellizzi AM
    Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.